Approval · Notice of Compliance 21745 · 2019
ZOLADEX: Notice of Compliance 21745
Issued January 10, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21745
- Date
- January 10, 2019
- Company
- Tersera Therapeutics LlcDeerfield, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to the carton labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLADEX | Not yet assigned | — |
| ZOLADEX LA | Not yet assigned | — |
Medicinal ingredients
- GOSERELIN ACETATE 3.6 MG per IMP
- GOSERELIN ACETATE 10.8 MG per IMP